Home › NDC Lookup › RxCUI directory › RxCUI 1241471

Carboxymethylcellulose sodium 5 MG/ML / glycerin 10 MG/ML / polysorbate 80 5 MG/ML Ophthal... — RxCUI 1241471

RxNorm drug concept · Semantic clinical drug
RxCUI 1241471 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 16 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1241471
Official nameCarboxymethylcellulose sodium 5 MG/ML / glycerin 10 MG/ML / polysorbate 80 5 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascarboxymethylcellulose sodium 0.5 % / glycerin 1 % / polysorbate 80 0.5 % Ophthalmic Solution
FDA products mapped9
Package NDCs mapped16
Reported Medicaid activity (SDUD)11,821 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Carboxymethylcellulose sodium 5 MG/ML / glycerin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Carboxymethylcellulose sodium 5 MG/ML / glycerin 10 MG/ML / polysorbate 80 5 MG/ML Ophthalmic Solution RxCUI 1241471

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Carboxymethylcellulose 2062
    • Glycerin 4910
    • Polysorbate 80 8560
    • Carboxymethylcellulose / glycerin / polysorbate 80 1241470
    • Carboxymethylcellulose sodium 491498
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Carboxymethylcellulose / glycerin / polysorbate 80 Ophthalmic Solution 1241469
    • Carboxymethylcellulose sodium / glycerin / polysorbate 80 Ophthalmic Solution 2647870
    • Carboxymethylcellulose / glycerin / polysorbate 80 Ophthalmic Product 1241468
    • Carboxymethylcellulose sodium / glycerin / polysorbate 80 Ophthalmic Product 2659642
    • Ophthalmic Solution 7670
    • Ophthalmic Product 1151135
  3. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Carboxymethylcellulose sodium 5 MG/ML 1100648
    • Glycerin 10 MG/ML 315993
    • Polysorbate 80 5 MG/ML 334402

Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Carboxymethylcellulose sodium 5 MG/ML SCDC · 1100648
  • Glycerin 10 MG/ML SCDC · 315993
  • Polysorbate 80 5 MG/ML SCDC · 334402
  • Carboxymethylcellulose / glycerin / polysorbate 80 Ophthalmic Solution SCDF · 1241469
  • Carboxymethylcellulose sodium / glycerin / polysorbate 80 Ophthalmic Solution SCDFP · 2647870
  • Carboxymethylcellulose / glycerin / polysorbate 80 Ophthalmic Product SCDG · 1241468
  • Carboxymethylcellulose sodium / glycerin / polysorbate 80 Ophthalmic Product SCDGP · 2659642

📦 FDA Products & Package NDCs

9 products · 16 package NDCs
16 package NDCs map to RxCUI 1241471 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00023-3988-05 1 VIAL in 1 CARTON (0023-3988-05) / 10 mL in 1 VIAL Refresh Optive Mega-3 PF Allergan, Inc. 2026-03-01
00023-3988-10 1 VIAL in 1 CARTON (0023-3988-10) / 10 mL in 1 VIAL Refresh Optive Mega-3 PF Allergan, Inc. 2026-03-01
00023-4230-70 70 VIAL, SINGLE-USE in 1 BOX (0023-4230-70) / .4 mL in 1 VI... REFRESH Optive Mega-3 Allergan, Inc. 2024-07-01
00023-4307-02 1 BOTTLE in 1 CARTON (0023-4307-02) / 2 mL in 1 BOTTLE REFRESH OPTIVE Advanced Allergan, Inc. 2011-11-30
00023-4307-10 1 BOTTLE, DROPPER in 1 CARTON (0023-4307-10) / 10 mL in 1 B... REFRESH OPTIVE Advanced Allergan, Inc. 2011-11-30
00023-4307-20 2 BOTTLE, DROPPER in 1 CARTON (0023-4307-20) / 10 mL in 1 B... REFRESH OPTIVE Advanced Allergan, Inc. 2011-11-30
00023-4491-05 5 VIAL, SINGLE-USE in 1 CARTON (0023-4491-05) / .4 mL in 1... REFRESH OPTIVE Advanced Allergan, Inc. 2013-01-15
00023-4491-30 30 VIAL, SINGLE-USE in 1 CARTON (0023-4491-30) / .4 mL in 1... REFRESH OPTIVE Advanced Allergan, Inc. 2013-01-15
00023-5773-05 5 VIAL, SINGLE-USE in 1 BOX (0023-5773-05) / .4 mL in 1 VIA... REFRESH Optive Mega-3 Allergan, Inc. 2017-05-30
00023-5773-30 30 VIAL, SINGLE-USE in 1 BOX (0023-5773-30) / .4 mL in 1 VI... REFRESH Optive Mega-3 Allergan, Inc. 2017-05-30
00023-6952-02 1 BOTTLE, DROPPER in 1 CARTON (0023-6952-02) / 2 mL in 1 BO... Refresh Digital Allergan, Inc. 2020-08-01
00023-6952-10 1 BOTTLE, DROPPER in 1 CARTON (0023-6952-10) / 10 mL in 1 B... Refresh Digital Allergan, Inc. 2020-08-01
00023-6954-05 1 VIAL, PLASTIC in 1 CARTON (0023-6954-05) / .4 mL in 1 VIA... Refresh Digital PF Allergan, Inc. 2020-08-01
00023-6954-30 30 VIAL, PLASTIC in 1 CARTON (0023-6954-30) / .4 mL in 1 VI... Refresh Digital PF Allergan, Inc. 2020-08-01
00023-7151-60 60 VIAL, SINGLE-USE in 1 BOX (0023-7151-60) / .4 mL in 1 VI... REFRESH Optive Mega-3 Allergan, Inc. 2021-06-15
85211-0002-01 1 BOTTLE, DROPPER in 1 CARTON (85211-002-01) / 5 mL in 1 BO... Droptics Dry Eye Relief Droptics LLC 2025-02-01
Observed labelers: Allergan, Inc. (15) · Droptics LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.